Holen Sie sich die Stockscreener-App
1.15
3.36%
-0.04
Schlusskurs vom Vortag:
$1.19
Offen:
$1.2
24-Stunden-Volumen:
72,720
Relative Volume:
0.12
Marktkapitalisierung:
$979.28K
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1347
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-0.86%
1M Leistung:
-14.18%
6M Leistung:
-87.14%
1J Leistung:
-97.34%
1-Tages-Spanne:
$1.13
$1.20
1-Wochen-Bereich:
$1.13
$1.20
52-Wochen-Spanne:
$1.03
$42.00
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.15 | 979.28K | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
How sentiment analysis helps forecast Oragenics Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser
Backtesting results for Oragenics Inc. trading strategiesTrade Signal Summary & Safe Capital Investment Plans - Newser
What to do if you’re stuck in Oragenics Inc.Forecast Cut & Growth-Oriented Investment Plans - Newser
How to forecast Oragenics Inc. trends using time seriesEarnings Overview Report & Risk Controlled Daily Trade Plans - Newser
Oragenics Inc. Stock Performance After Earnings: Historical InsightsJuly 2025 Opening Moves & Fast Gaining Stock Reports - Newser
Real time social sentiment graph for Oragenics Inc.July 2025 Intraday Action & Daily Chart Pattern Signals - Newser
Strategies to average down on Oragenics Inc.2025 Key Highlights & Consistent Return Investment Signals - Newser
What makes Oragenics Inc. stock price move sharplyMarket Activity Summary & Free High Return Stock Watch Alerts - Newser
Tools to assess Oragenics Inc.’s risk profileWeekly Risk Report & High Conviction Trade Alerts - Newser
Published on: 2025-08-12 22:56:34 - Newser
Has Oragenics Inc. found a price floorFree Strong Buy With Technical Confidence - Newser
Smart tools for monitoring Oragenics Inc.’s price actionPrice Action Summary and Entry Strategy Guide - Newser
Oragenics Q2 EPS Beats Expectations, CEO Hails "New Era of Brain-First Recovery" - AInvest
Oragenics Secures $16.5M in Funding, Plans Q3 2025 Trials for Concussion Treatment - AInvest
Oragenics Inc. Advances ONP-002 Toward Phase IIa Concussion Trial with Strategic Q2 2025 Milestones - citybuzz -
Oragenics advances toward phase IIa trials for concussion treatment - Investing.com
Oragenics Advances Brain-First Recovery Platform Toward Clinical Milestones for Concussion Treatment - AInvest
Oragenics Q2 2025 Shareholder Update - GlobeNewswire
Oragenics Advances Brain-First Recovery Platform Toward Clinical Milestones. - AInvest
Oragenics Inc. stock trend forecastConservative Asset Allocation Risk Analysis - Newser
Is this a good reentry point in Oragenics Inc.Free Daily Stock Market Swing Alerts - Newser
Using fundamentals and technicals on Oragenics Inc.Buy Alert Based on RSI and Volume - Newser
How Oragenics Inc. stock performs during market volatilityLow Drawdown Stock Screener with Analysis - Newser
Is Oragenics Inc. a strong growth stockExplosive Potential Mid Cap Picks - mustnews.co.kr
Will Oragenics Inc. outperform the market in YEARReversal Pattern Breakout Alerts - mustnews.co.kr
Quantitative breakdown of Oragenics Inc. recent moveFree Stock Market Watch With Alerts - Newser
Can Oragenics Inc. maintain sales growthBig Profit Trading Alerts - mustnews.co.kr
Published on: 2025-08-09 21:31:02 - Newser
Evaluating Oragenics Inc. with trendline analysisFast Entry Strategy with Price Prediction - Newser
Oragenics: Q2 Earnings Snapshot - San Antonio Express-News
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):